Celescreen
2014
FOUNDED
PRIVATE
STATUS
Accelerator/Inc
LATEST DEAL TYPE
1
INVESTORS
Description
Developer of alternative toxicology testing methods. The company uses C. elegans worms to test the toxicity levels of consumer products in the fields of pharmaceuticals, cosmetics, and food products.
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Commercial Services
Primary Office
- 96 Bis Boulevard Raspail
- 75006 Paris
- France
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Celescreen’s full profile, request a free trial.
Celescreen Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Accelerator/Incubator | 11-Sep-2014 | Completed | Product Development |
Celescreen Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Agoranov | Accelerator/Incubator | 000 0000 | 000000 0 |